We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





BD Presents Latest Innovations in Patient Safety at Arab Health and MEDLAB Middle East

By LabMedica International staff writers
Posted on 24 Jan 2022
Print article
Image: BD Presents Latest Innovations in Patient Safety at Arab Health and MEDLAB Middle East  (Photo courtesy of Becton, Dickinson and Company)
Image: BD Presents Latest Innovations in Patient Safety at Arab Health and MEDLAB Middle East (Photo courtesy of Becton, Dickinson and Company)

Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) participated and shared insights with cutting-edge technology solutions enhancing the patient care journey at this year’s Arab Health and MEDLAB 2022 held at the Dubai World Trade Centre.

BD presented its latest innovations and solutions focused on patient safety to support clinicians’ efforts to move from piecemeal interventions to a total systems approach for safety at two of the region’s leading medical technology events. At Arab Health 2022, the company demonstrated the full potential of its innovations through the collaboration of its Medical segment with Medication Management Systems and Medication Delivery Systems, and the BD Interventional segment. BD displayed a series of solutions that focused on the prevention of potential medication errors and Healthcare-Associated Infections (HAIs) alongside innovations that empower medical professionals to perform timely, accurate and appropriate diagnostics practices to support effective decision making in providing the safest and most effective care possible in the region.

Additionally, at MEDLAB 2022, the company’s Lifesciences segment showcased integrated diagnostic solutions and services, including safe and integrated specimen collection, specimen diagnosis and data management for better patient comfort. The company also presented solutions that incorporate artificial intelligence to drive laboratory efficiency with customized microbiology automation platforms and dedicated value-added services. Additionally, experts from BD hosted several sessions that addressed the challenges in patient and healthcare worker safety in the post pandemic world. They also highlighted the best practices and demonstrated a variety of services and solutions to help equip healthcare providers in the region with the safe tools leading to better medication management decisions and patient treatment outcomes.

“The pandemic put the healthcare sector to the test in terms of stability and preparedness, demonstrating the need for healthcare providers to adopt advanced technology to meet the growing needs of patients,” said Maher Elhassan, Vice President and General Manager, BD Middle East, North Africa, and Turkey. “Avenues like Arab Health and Medlab give us an invaluable opportunity to raise awareness while facilitating the necessary impetus to our movement of securing and improving the patient care journey for both medical professionals and patients alike. Now more than ever, is the time for organizations and medical institutions to collaborate and achieve greater milestones in patient safety and BD will do everything in its capacity to provide best-in-class MedTech products and services, as we pursue our purpose of advancing the world of health.”

Related Links:
Becton, Dickinson and Company

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.